Get Your Personalized Supplement StackSupplement Stack Quiz

Bupleurum Falcatum

Also known as: Chinese thorowax, sickle-leaved hare’s ear, Bupleuri radix, Bupleurum falcatum

Overview

Bupleurum falcatum, also known as Chinese thorowax or sickle-leaved hare’s ear, is a perennial herb widely utilized in Traditional Chinese Medicine (TCM), primarily its root, referred to as Bupleuri radix. It is valued for its anti-inflammatory, hepatoprotective, and adaptogenic properties. The herb contains active compounds called saikosaponins, which are believed to be responsible for its diverse pharmacological effects. Historically, B. falcatum has been applied in the treatment of respiratory infections, liver diseases, mood disorders, and conditions related to fatigue. While research on B. falcatum is ongoing, with a mix of in vitro, animal, and some human clinical studies, high-quality randomized controlled trials (RCTs) are still limited. The existing evidence quality varies, and while some systematic reviews exist, they often highlight methodological limitations in the primary studies, indicating a need for more robust research.

Benefits

Bupleurum falcatum shows potential benefits across several areas, though the strength of evidence varies. For Chronic Fatigue Syndrome (CFS), a meta-analysis of Chinese herbal medicines, including Bupleurum species, indicated improved fatigue symptoms with a relative risk (RR) of 1.41 (95% CI: 1.33–1.49), suggesting a moderate benefit in fatigue reduction. However, these studies often involved mixed herbal formulas. In the context of Acute Respiratory Tract Infections (ARTI), a systematic review found low to very low quality evidence for Bupleuri radix, with no high-quality RCTs confirming efficacy, and safety data were also limited. For depression, a systematic review and meta-analysis on Bupleurum chinense-containing formulas reported some efficacy in reducing symptoms of Major Depressive Disorder (MDD), but this evidence was constrained by study quality and heterogeneity. Animal studies suggest B. falcatum extracts may attenuate stress-induced cognitive impairment by preserving cholinergic function in the hippocampus and may reduce hyperthyroidism-induced oxidative stress.

How it works

The primary active constituents of Bupleurum falcatum are saikosaponins, which are responsible for its diverse pharmacological actions. These compounds exert anti-inflammatory, immunomodulatory, and hepatoprotective effects by modulating cytokine production and inhibiting various inflammatory pathways. Saikosaponins also exhibit antioxidant activity and can regulate neurochemical systems, such as cholinergic pathways in the brain, which may contribute to its cognitive and mood-related benefits. In vitro studies suggest saikosaponins may induce apoptosis in tumor cells and inhibit telomerase activity, indicating potential antitumor effects. While the exact bioavailability and pharmacokinetics in humans are not fully characterized, traditional use involves decoctions or extracts standardized to their saikosaponin content.

Side effects

Bupleurum falcatum is generally considered relatively safe when used in traditional dosages, but comprehensive, high-quality safety data from clinical trials are scarce. Common side effects are not well documented in modern research; however, traditional texts mention the possibility of gastrointestinal discomfort. There have been no significant drug interactions or contraindications robustly identified in clinical trials to date. A significant concern regarding safety is quality control, as variability in the plant source and extraction methods can lead to differences in the concentration of active constituents, potentially affecting both efficacy and safety. Due to the lack of sufficient safety data, caution is strongly advised for pregnant or breastfeeding women, and its use in these populations is not recommended without professional medical guidance.

Dosage

There is no standardized dosing for Bupleurum falcatum root extracts established through rigorous clinical trials. Traditional use typically involves consuming 3–9 grams of dried root per day, prepared as a decoction. The optimal dosage can vary significantly depending on the specific preparation type (e.g., aqueous extract, acetone extract) and the particular health condition being addressed. It is important to note that many clinical trials reviewed often lack detailed dosing information or standardization, which limits the ability to provide precise, evidence-based recommendations for modern supplement use. Users should be aware that product formulations can differ, and it is advisable to follow manufacturer guidelines or consult with a qualified healthcare practitioner for personalized dosage advice.

FAQs

Can it treat depression?

Limited evidence indicates potential benefit in reducing depressive symptoms when used as part of multi-herb formulas, but it is not established as a standalone treatment for depression.

Is it safe?

Bupleurum falcatum is generally considered safe in traditional dosages, but high-quality safety data from modern clinical trials are lacking, especially regarding long-term use or specific populations.

When to take it?

Traditionally, it is taken as a decoction. The timing of intake can vary based on the specific formulation and the condition being treated, and there are no universally established guidelines.

Research Sources

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.958005/full – This meta-analysis investigated the efficacy of Chinese herbal medicines, including Bupleurum species, for chronic fatigue syndrome. It found that these herbal interventions significantly improved fatigue symptoms, with a relative risk of 1.41, suggesting a moderate benefit. However, the study noted heterogeneity and the use of mixed herbal formulas as limitations.
https://vellmanherbs.com/wp-content/uploads/2024/01/bupleurum-saikosaponins.pdf – This source discusses the active compounds, saikosaponins, found in Bupleurum falcatum. It highlights their anti-inflammatory, immunomodulatory, and hepatoprotective effects, as well as potential roles in modulating cytokine production and regulating neurochemical systems. The document also mentions in vitro evidence for potential antitumor effects.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.787084/full – This systematic review assessed the efficacy and safety of Bupleuri radix for acute upper respiratory tract infections. It concluded that the evidence for its efficacy was of low to very low quality, with no high-quality randomized controlled trials confirming benefits. The review also highlighted a high risk of bias and limited safety data in the included studies.
https://pubmed.ncbi.nlm.nih.gov/31328996/ – This systematic review and meta-analysis evaluated Bupleurum chinense-containing formulas for major depressive disorder. It reported some efficacy in reducing depressive symptoms, but the findings were limited by small sample sizes, poor blinding, and significant heterogeneity among the included studies, leading to a low to moderate quality assessment.